Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.42 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
| ▸ | RRM2 | P31350 | 1/20 | 0.39 |
| ▸ | RRM2B | Q7LG56 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30035925 | 0.90 | CASP3 (0.43) | CASP3TNFPTPN1 | |
| SCHEMBL29709487 | 0.90 | CASP3 (0.46) | CASP3MMERRM1RRM2RRM2B | |
| SCHEMBL29696715 | 0.90 | CASP3 (0.48) | CASP3TNFMDM4TP53 | |
| SCHEMBL22605622 | 0.89 | CASP3 (0.36) | CASP3RRM1RRM2RRM2BPTPN1 | |
| SCHEMBL29860758 | 0.86 | MME (0.46) | CASP3MMEECE1 | |
| SCHEMBL30036912 | 0.86 | CASP3 (0.42) | CASP3TNFPTPN1MDM4TP53 | |
| SCHEMBL30036228 | 0.85 | ACE (0.40) | — | |
| SCHEMBL30034829 | 0.85 | CASP3 (0.41) | CASP3TNFPTPN1MDM4TP53 | |
| SCHEMBL24579736 | 0.84 | CASP3 (0.45) | CASP3PTPN1MDM4TP53 | |
| SCHEMBL24579184 | 0.84 | CASP3 (0.45) | CASP3PTPN1MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111479819-B | Method for preparing peptide and method for treating alkali | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| US-11492369-B2 | Method for producing peptide, and method for processing bases | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492369-B2 | Method for producing peptide, and method for processing bases | VIP, NPPA, PTMS | CASP3 3776/4885MME 73/4885RRM1 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.